Login
Manage Portfolio
Post a StockTalk
Write an Instablog
Get Daily Email Alert
Seeking Alpha
Home
The Macro View
Stocks & Sectors
Global Markets
ETFs
Investing Ideas
Breaking News
Transcripts
Business Intelligence
Schering-Plough Corp. (SGP)
(
)
Quote & Articles
Transcripts
Instablogs
StockTalks
Comments on articles
(1 new today)
Cramer
Authors on SGP
Newest on SGP
M. E. Garza
(2)
The Burrill Report
(1)
Marco Hickey
(1)
Smart Profits Report
(1)
Larry Rothman
(2)
Most frequent on SGP
SA Editor Miriam Metzinger
(
80
)
Mike Huckman
(
31
)
Jeffrey Saut
(
15
)
SA Editor Eli Hoffmann
(
13
)
Market Folly
(
12
)
Most followed on SGP
Philip Davis
(
2635
)
Don Dion
(
2256
)
Bespoke Investment Group
(
2208
)
Trader Mark
(
2077
)
SA Editor Rachael Granby
(
1319
)
Most commented on SGP
SA Editor Eli Hoffmann
(
130
)
SA Editor Miriam Metzinger
(
79
)
SA Editor Rachael Granby
(
53
)
Mike Huckman
(
41
)
Jeffrey Saut
(
37
)
52wk high:
52wk low:
EPS:
PE:
Dividend:
Yield:
Market Cap:
Exchange:
Articles on Schering-Plough Corp. (SGP)
by
latest
|
most commented
Dan Loeb's Third Point Hedge Fund Favoring 'Blank Check' Companies
Jul 10
•
Market Folly
•
DEPO
,
AMED
,
CORE
•
1 Comment
|
Quick Read
Clarium Makes Huge Play on Oil Services
Jul 2
•
Market Folly
•
BBY
,
AXP
,
BEXP
•
2 Comments
|
Quick Read
Generic Players Continue to Impress in H1
Jul 2
•
EP Vantage
•
ABBI
,
ALO
,
ACL
•
Comment!
|
Quick Read
Why I'm Shifting Portfolio Sector Weightings
Jul 1
•
Ryan Barnes
•
PFE
,
SGP
•
1 Comment
|
Quick Read
Smaller Pharma Wins the 'Most Valuable' Race
Jul 1
•
EP Vantage
•
AMGN
,
ALKS
,
CELG
•
1 Comment
|
Quick Read
Hedge Fund Moore Stakes Out Energy Bets
Jul 1
•
Market Folly
•
ACE
,
AMR
,
ATVI
•
1 Comment
|
Quick Read
Six Contraception and Birth Control Stocks
Jun 29
•
Stockerblog
•
JNJ
,
BAYRY.PK
,
CHD
•
1 Comment
|
Quick Read
Not-Ready-For-Prime-Time Stock List
Jun 28
•
Ryan Barnes
•
ADTN
,
BBBY
,
BHI
•
3 Comments
|
Quick Read
FDA Extreme Trades: 16 Stocks Under 5 Bucks
Jun 28
•
Mike Havrilla
•
CTIC
,
APPA
,
ANPI
•
9 Comments
|
Quick Read
Pharma M&A: Big Bonds and Small Deals
Jun 26
•
The Burrill Report
•
BMTI
,
CNSO.OB
,
AFPC
•
Comment!
|
Quick Read
Selling Schering Plough, Looking to India, Brazil and South Africa
Jun 25
•
Ryan Barnes
•
SGP
,
MRK
•
4 Comments
|
Quick Read
51 Option Ideas for Bears
Jun 23
•
Marco Hickey
•
AMGN
,
ABT
,
AAPL
•
2 Comments
|
Quick Read
Biotech Set to Capture 50% of Top 100 Drugs by 2014
Jun 19
•
Research Recap
•
NVS
,
PFE
,
MRK
•
1 Comment
|
Quick Read
Biotech Set to Dominate Drug Industry Growth
Jun 18
•
EP Vantage
•
AMGN
,
JNJ
,
ABT
•
Comment!
|
Quick Read
Merck Needs Schering-Plough
Jun 16
•
Zacks.com
•
SGP
,
MRK
•
Comment!
|
Quick Read
Is Low Quality Leading the Market?
Jun 15
•
Richard Shaw
•
AAN
,
AMNB
,
AMRB
•
5 Comments
|
Quick Read
Nine Value Companies to Watch
Jun 10
•
Value Expectations
•
BIIB
,
BMY
,
APOL
•
3 Comments
|
Quick Read
Five Extreme Biotech Trades
Jun 10
•
Mike Havrilla
•
AUXL
,
ACAD
,
ANPI
•
Comment!
|
Quick Read
Galleon Bets Heavily on the S&P 500
Jun 9
•
Market Folly
•
AMAG
,
AMD
,
AMAT
•
Comment!
|
Quick Read
Bio Medical Stock Sector is Where the Action Is
Jun 9
•
M. E. Garza
•
ALNY
,
AGEN
,
ANPI
•
Comment!
|
Quick Read
30 Attractive Companies Under $30: Fidelity's Low Priced Stock Fund Part II
Jun 8
•
Value Expectations
•
AMD
,
BMY
,
AES
•
8 Comments
|
Quick Read
Biggest Health Care Winners Become Biggest Losers After Friday's Market Action
Jun 7
•
M. E. Garza
•
BDSI
,
AGEN
,
COV
•
1 Comment
|
Quick Read
Health Care Trends Part 2: M&A, Generic Competition, CROs
Jun 7
•
Bullish Bankers
•
CVTX
,
CVD
,
GILD
•
4 Comments
|
Quick Read
Hedge Fund Eton Park Saw Golden Opportunities in Q109
May 27
•
Market Folly
•
AA
,
AKAM
,
AGN
•
2 Comments
|
Quick Read
Schering Plough's Mysterious Suitor Before Merck
May 25
•
Vincent Fernando
•
PFE
,
SGP
,
MRK
•
Comment!
|
Quick Read
J&J Will Not Let Merck Go Quietly to Schering-Plough
May 22
•
Derek Lowe
•
SGP
,
MRK
,
JNJ
•
Comment!
|
Quick Read
J&J Mounts Remicade Challenge
May 21
•
Zacks.com
•
SGP
,
MRK
,
JNJ
•
2 Comments
|
Quick Read
What's John Paulson Buying Now? Hint... Think Gold
May 20
•
Market Folly
•
BCE
,
BSX
,
AU
•
12 Comments
|
Quick Read
Personalized Medicine: The Next Big Thing
Apr 29
•
Andrew Mickey
•
DNA
,
LLY
,
GSK
•
5 Comments
|
Quick Read
FDA, Clinical Trial Updates: Pro-Pharma Looks Promising
Apr 26
•
Mike Havrilla
•
MEDX
,
SGP
,
JNJ
•
5 Comments
|
Quick Read
Merck and United Health Group: Unprepared for Obama's Healthcare Reform
Apr 22
•
Michael Steinberg
•
UNH
,
SGP
,
MRK
•
5 Comments
|
Quick Read
Wall Street Breakfast: Must-Know News
Apr 21
•
SA Editor Rachael Granby
•
ALV
,
BAC
,
BRO
•
22 Comments
|
Quick Read
Galleon's Q408: SPY Pays Off Alongside Reduced Equity Positions
Apr 21
•
Market Folly
•
AEO
,
ADI
,
AAPL
•
Comment!
|
Quick Read
S&P 500 Stocks Furthest Above 200-Day Moving Averages
Apr 17
•
Bespoke Investment Group
•
AZO
,
AN
,
AMZN
•
3 Comments
|
Quick Read
IHE: Large-Cap Pharma Continues to Blow Away the S&P 500
Apr 13
•
Don Dion
•
BMY
,
AGN
,
ABT
•
1 Comment
|
Quick Read
A Look at M & A Arbitrage Activity
Apr 8
•
Jae Jun
•
ABNJ
,
AANB
,
ACBA
•
Comment!
|
Quick Read
A Pharma Merger Arb Trade for You
Apr 6
•
Chad Brand
•
SGP
,
MRK
•
Comment!
|
Quick Read
S&P 500 Watch: March 'Winners' Are Actually the Biggest Losers
Mar 29
•
Alan Brochstein
•
BAC
,
ABT
,
AAPL
•
10 Comments
|
Quick Read
U.S. Prescription Drug Sales Grow Slowly; Hydrocodone Most Prescribed
Mar 26
•
Marketing Charts
•
BMY
,
IHE
,
GSK
•
10 Comments
|
Quick Read
Short Interest Rises in Merck and Johnson & Johnson
Mar 25
•
Data Explorers
•
SGP
,
MRK
,
JNJ
•
3 Comments
|
Quick Read
Is the Winner Pfizer, Merck or Roche?
Mar 20
•
Larry Rothman
•
DNA
,
PFE
,
MRK
•
11 Comments
|
Quick Read
1
2
3
4
5
6
Next Page